trial

Therapeutic Drug Monitoring for Individualized Clozapine Therapy

NCTId NCT03523741
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Unknown
Enrollment 100 (estimated)
Sponsored by Seoul National University Hospital
Primary completion 2020-11-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
100 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2018-06-13
Primary completion
2020-11-30
Eligibility
ALL · 19 Years

Interventions & indications

Drugs
Clozapine

Sponsors

Seoul National University HospitalLead Sponsor

Investigators

1
Sang-In Park, Ph. D.Study Chair

Sites

1 total
Seongnam, South Korea

Facts & assertions

4 sourced
Enrollment
100
Phase
NA
Primary Completion Date
2020-11-30
Status
UNKNOWN
relationships
The graph out of here
drug
Clozapine
drug
lead_sponsor
Seoul National University Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
Drug-Related Side Effects and Adverse Reactions
indication
investigator
Sang-In Park, Ph. D.
person